{"id":"W3213542315","doi":"10.1016/s2152-2650(21)02075-9","title":"OAB-001: Overall survival and progression-free survival by treatment duration with Daratumumab + Lenalidomide/Dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: phase 3 MAIA study","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Multiple myeloma; Daratumumab; Dexamethasone; Clinical endpoint; Hazard ratio; Interim analysis; Surgery; Gastroenterology; Oncology; Confidence interval; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003570546,0.002479318,0.002932111,0.0005564547,0.0005961092,0.002281789,0.002003224,0.001558381,0.003378537],"category_scores_gemma":[0.00164492,0.0008548871,0.003701289,0.0008077341,0.001431358,0.001449237,0.001064582,0.005080225,0.0008878841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001832019,"about_ca_system_score_gemma":0.002349595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002743178,"about_ca_topic_score_gemma":0.005660201,"domain_scores_codex":[0.9989604,0.0005139973,0.00004144777,0.0001863518,0.0001110919,0.0001867722],"domain_scores_gemma":[0.9976847,0.0003633477,0.0006621027,0.0001791913,0.000081064,0.001029578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9159672,0.01503119,0.02443735,0.0004881336,0.004927432,0.00007035377,0.0001811876,0.002092178,0.007787074,0.0002025881,0.002758706,0.02605668],"study_design_scores_gemma":[0.6479371,0.2058959,0.1326787,0.00008756801,0.005267685,0.0002437088,0.0001647923,0.00249476,0.001752933,0.0004662682,0.002907014,0.0001034973],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935138,0.002337207,0.0001795231,0.0003808128,0.00007940721,0.0003800476,0.002336676,0.00004916186,0.0007434363],"genre_scores_gemma":[0.9884874,0.001887198,0.000595446,0.0007979034,0.0002043779,0.000978886,0.005107262,0.00004893096,0.001892752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003570546,"threshold_uncertainty_score":0.01888305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04464540784505627,"score_gpt":0.3670065401425495,"score_spread":0.3223611322974932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}